MOH Research Note — The Cost Ratio Test
Molina’s cash flow supports the recovery case, while Marketplace losses and the October medical-cost test keep conviction limited.
Molina’s cash flow supports the recovery case, while Marketplace losses and the October medical-cost test keep conviction limited.
Molina’s cash flow and long-term structure support recovery, but Marketplace losses and Medicaid policy pressure leave little room for error.
UnitedHealth has two quarters of medical-cost improvement, but the recovery remains narrow and legal risk is unresolved.
UnitedHealth has two quarters of medical-cost improvement, while flat revenue, weaker Optum results and federal scrutiny keep the recovery conditional.